Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say
Researchers at the University of Kentucky have found that an experimental Alzheimer's drug, MW150, may help reduce brain inflammation associated with alcohol withdrawal. The drug targets a specific inflammation pathway and has shown promise in laboratory and animal-model studies. This research suggests that MW150 could potentially mitigate the risks of relapse in individuals with alcohol use disorder.
- ▪MW150 is an investigational drug designed to treat mild to moderate Alzheimer's disease.
- ▪The drug was found to reduce inflammatory markers during alcohol withdrawal in laboratory and animal-model experiments.
- ▪Scientists believe that neuroinflammation contributes to relapse risk and long-term neurological damage in people with alcohol use disorder.
Fox News — Latest files mainly under news. We currently carry 3,552 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Fox News |
| Canonical URL | https://www.foxnews.com/health/experimental-alzheimers-drug-could-reduce-alcohol-withdrawal-damage-researchers-say |
| Publication time | Mon, 25 May 2026 07:00:56 -0400 |
| Retrieval time | 2026-05-25T11:12:36.628Z |
| Last seen | 2026-05-25T11:29:02.871Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | LSGCwxMdOORT |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Health Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say MW150 was found to reduce inflammatory markers in lab and animal-model experiments By Melissa Rudy Fox News Published May 25, 2026 7:00am EDT Facebook Twitter Threads Flipboard Comments Print Email Add Fox News on Google close Video Jillian Michaels hails ‘fantastic’ trend as American alcohol use hits new low Jillian Michaels joins 'Fox & Friends' to discuss falling U.S. drinking rates and a new study linking walking to fat burning and weight loss. NEWYou can now listen to Fox News articles! An investigational dementia drug may also ease alcohol withdrawal by calming the brain inflammation linked to addiction and relapse.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fox News.